phentermine and lorcaserin

phentermine has been researched along with lorcaserin in 51 studies

Research

Studies (51)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	49 (96.08)	24.3611
2020's	2 (3.92)	2.80

Authors

Authors	Studies
Kaplan, LM	1
Hay, M	1
Goldfine, AB; Hiatt, WR; Thomas, A	1
Bello, NT; Campbell, SC	1
Bouchie, A	1
Colman, E; Egan, A; Golden, J; Roberts, M; Rosebraugh, C; Weaver, J	1
Johnson, AM	1
Carter, R; Mouralidarane, A; Oben, J; Ray, S; Soeda, J	1
Hermayer, K; Holes-Lewis, KA; Malcolm, R; O'Neil, PM	1
Howland, RH	1
Murfin, M	1
Padwal, RS; Rueda-Clausen, CF; Sharma, AM	1
Charakida, M; Finer, N; Tousoulis, D	1
Kelly, EM; Tungol, AA; Wesolowicz, LA	1
Blomain, ES; Kim, GW; Lin, JE; Waldman, SA	1
le Roux, CW; Miras, AD	1
Schwartz, LM; Woloshin, S	1
Azebu, LM	1
Nakazato, M; Ueno, H	1
Ebbert, JO; Edakkanambeth Varayil, J; Hurt, RT	1
Aldhoon-Hainerová, I; Hainer, V	1
Hainer, V	1
Bray, GA	1
Ryan, DH	1
Diamond, F	1
Cunningham, JW; Wiviott, SD	1
Citrome, L	1
Rubio, MA	1
Mehr, SR; Zimmerman, MP	1
Dahiya, N; Kakkar, AK	1
Aronne, LJ; Kumar, RB	1
Fujioka, K	1
Bragg, R; Crannage, E	1
Megyeri, J; Nuffer, W; Trujillo, JM	1
Camilleri, M; Chandar, AK; Dulai, PS; Khera, R; Loomba, R; Murad, MH; Prokop, LJ; Singh, S; Wang, Z	1
Braverman-Panza, J; Fujioka, K	1
Aronne, LJ; Igel, LI; Kumar, RB; Saunders, KH	1
Curry, SA	1
Gadde, KM; Pritham Raj, Y	1
Aronne, LJ; Fain, R; Fujioka, K; Garvey, WT; Greenway, FL; Pilson, R; Smith, SR; Zhou, S	1
Golden, A	1
Grabarczyk, TR	1
Bersoux, S; Byun, TH; Chaliki, SS; Poole, KG	1
Aronne, LJ; Coulter, AA; Fujioka, K; Garvey, WT; Greenway, FL; Nikonova, EV; Rebello, CJ; Smith, SR; Zhou, S	1
Aronne, LJ; Chukir, T; Saunders, KH; Shukla, AP	1
Nadolsky, KZ	1
Andrew, CA; Aronne, LJ; Saunders, KH; Shukla, AP	1
Gorelik, B; Gorelik, E; Hirsh-Raccah, B; Masarwa, R; Matok, I; Perlman, A	1
Lee, SY; Tak, YJ	1

Reviews

27 review(s) available for phentermine and lorcaserin

Article	Year
Pharmacologic therapies for obesity. Gastroenterology clinics of North America, 2010, Volume: 39, Issue:1 Topics: Anti-Obesity Agents; Appetite Depressants; Bariatric Surgery; Benzazepines; Bupropion; Cyclobutanes; Ephedrine; Fenfluramine; Humans; Lactones; Naltrexone; Obesity; Orlistat; Phentermine; Weight Gain; Weight Loss	2010
Recent advancements in drug treatment of obesity. Clinical medicine (London, England), 2012, Volume: 12, Issue:5 Topics: Anti-Obesity Agents; Benzazepines; Benzoxazines; Bupropion; Clinical Trials as Topic; Drug Combinations; Fructose; Glucagon-Like Peptide 1; Humans; Lactones; Life Style; Liraglutide; Naltrexone; Obesity; Orlistat; Phentermine; Topiramate; Weight Loss	2012
Pharmacotherapy of obesity: clinical treatments and considerations. The American journal of the medical sciences, 2013, Volume: 345, Issue:4 Topics: Anti-Obesity Agents; Benzazepines; Drug Therapy, Combination; Fructose; Humans; Obesity; Phentermine; Topiramate	2013
New pharmacological approaches for obesity management. Nature reviews. Endocrinology, 2013, Volume: 9, Issue:8 Topics: Appetite Depressants; Benzazepines; Drug Combinations; Fructose; Humans; Life Style; Obesity; Phentermine; Topiramate	2013
Drug treatment of obesity in the cardiovascular patient. Current opinion in cardiology, 2013, Volume: 28, Issue:5 Topics: Anti-Obesity Agents; Benzazepines; Cardiovascular Diseases; Fructose; Humans; Lactones; Obesity; Orlistat; Phentermine; Topiramate	2013
Formulary management of 2 new agents: lorcaserin and phentermine/topiramate for weight loss. Journal of managed care pharmacy : JMCP, 2013, Volume: 19, Issue:8 Topics: Adult; Anti-Obesity Agents; Appetite Depressants; Benzazepines; Body Weight; Clinical Trials, Phase III as Topic; Female; Fructose; Humans; Male; Obesity; Phentermine; Randomized Controlled Trials as Topic; Topiramate; Weight Loss	2013
Antiobesity pharmacotherapy: new drugs and emerging targets. Clinical pharmacology and therapeutics, 2014, Volume: 95, Issue:1 Topics: Animals; Anti-Obesity Agents; Benzazepines; Drug Combinations; Drug Delivery Systems; Drug Discovery; Fructose; Humans; Obesity; Phentermine	2014
Can medical therapy mimic the clinical efficacy or physiological effects of bariatric surgery? International journal of obesity (2005), 2014, Volume: 38, Issue:3 Topics: Anti-Obesity Agents; Bariatric Surgery; Benzazepines; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Type 2; Exercise; Feeding Behavior; Female; Fructose; Glucagon-Like Peptide-1 Receptor; Glucosides; Glycated Hemoglobin; Homeostasis; Humans; Islet Amyloid Polypeptide; Lactones; Male; Minimally Invasive Surgical Procedures; Obesity, Morbid; Orlistat; Phentermine; Receptors, Glucagon; Topiramate; Treatment Outcome; Weight Loss	2014
[Cutting-edge of medicine; the prospects of novel anti-obesity drugs]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2014, Mar-10, Volume: 103, Issue:3 Topics: Anti-Obesity Agents; Appetite; Appetite Depressants; Benzazepines; Benzoxazines; Bupropion; Clinical Trials as Topic; Drug Approval; Drug Combinations; Drug Discovery; Energy Metabolism; Enzyme Inhibitors; Fructose; Glucagon-Like Peptide 1; Humans; Hypothalamus; Lactones; Lipase; Liraglutide; Metabolic Syndrome; Naltrexone; Obesity; Orlistat; Phentermine; Topiramate	2014
New pharmacological treatments for the management of obesity. Current gastroenterology reports, 2014, Volume: 16, Issue:6 Topics: Anti-Obesity Agents; Benzazepines; Drug Approval; Drug Combinations; Fructose; Humans; Obesity; Phentermine; Topiramate; Treatment Outcome	2014
Tolerability and safety of the new anti-obesity medications. Drug safety, 2014, Volume: 37, Issue:9 Topics: Anti-Obesity Agents; Benzazepines; Benzoxazines; Bupropion; Chemistry, Pharmaceutical; Drug-Related Side Effects and Adverse Reactions; Fructose; Glucagon-Like Peptide 1; Humans; Liraglutide; Naltrexone; Obesity; Phentermine; Topiramate	2014
Overview of new antiobesity drugs. Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:14 Topics: Anti-Obesity Agents; Benzazepines; Benzoxazines; Bupropion; Drug Combinations; Fructose; Glucagon-Like Peptide 1; Humans; Liraglutide; Naltrexone; Obesity; Phentermine; Topiramate; Weight Loss	2014
Medical treatment of obesity: the past, the present and the future. Best practice & research. Clinical gastroenterology, 2014, Volume: 28, Issue:4 Topics: Anti-Obesity Agents; Benzazepines; Drug Therapy, Combination; Fructose; Humans; Lactones; Obesity; Orlistat; Phentermine; Topiramate; Weight Loss	2014
The pharmacological and surgical management of adults with obesity. The Journal of family practice, 2014, Volume: 63, Issue:7 Suppl Topics: Adult; Aged; Anti-Obesity Agents; Appetite Depressants; Bariatric Surgery; Benzazepines; Fructose; Humans; Lactones; Middle Aged; Obesity; Orlistat; Phentermine; Topiramate	2014
Modern obesity pharmacotherapy: weighing cardiovascular risk and benefit. Clinical cardiology, 2014, Volume: 37, Issue:11 Topics: Anti-Obesity Agents; Benzazepines; Bupropion; Cardiovascular Diseases; Clinical Trials as Topic; Drug Combinations; Fructose; Heart; Humans; Naltrexone; Obesity; Phentermine; Topiramate	2014
Drug treatment of obesity: current status and future prospects. European journal of internal medicine, 2015, Volume: 26, Issue:2 Topics: Anti-Obesity Agents; Benzazepines; Bupropion; Drug Combinations; Drug Therapy, Combination; Fructose; Humans; Lactones; Naltrexone; Obesity; Orlistat; Phentermine; Topiramate	2015
Efficacy comparison of medications approved for chronic weight management. Obesity (Silver Spring, Md.), 2015, Volume: 23 Suppl 1 Topics: Adult; Anti-Obesity Agents; Appetite Depressants; Benzazepines; Body Weight; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Female; Fructose; Humans; Obesity; Phentermine; Pilot Projects; Topiramate; Weight Loss	2015
Safety and tolerability of medications approved for chronic weight management. Obesity (Silver Spring, Md.), 2015, Volume: 23 Suppl 1 Topics: Anti-Obesity Agents; Benzazepines; Bupropion; Delayed-Action Preparations; Drug-Related Side Effects and Adverse Reactions; Drugs, Investigational; Fructose; Glucagon-Like Peptide 1; Humans; Liraglutide; Naltrexone; Obesity; Phentermine; Topiramate; United States; United States Food and Drug Administration; Weight Loss	2015
A Comparison of New Pharmacological Agents for the Treatment of Obesity. The Annals of pharmacotherapy, 2016, Volume: 50, Issue:5 Topics: Anti-Obesity Agents; Benzazepines; Bupropion; Clinical Trials, Phase III as Topic; Drug Combinations; Fructose; Humans; Liraglutide; Naltrexone; Obesity; Phentermine; Topiramate; Weight Loss	2016
Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis. JAMA, 2016, Jun-14, Volume: 315, Issue:22 Topics: Anti-Obesity Agents; Bayes Theorem; Benzazepines; Drug Combinations; Female; Fructose; Humans; Lactones; Liraglutide; Male; Middle Aged; Naltrexone; Obesity; Orlistat; Phentermine; Randomized Controlled Trials as Topic; Topiramate; Weight Loss	2016
Practical Use of Pharmacotherapy for Obesity. Gastroenterology, 2017, Volume: 152, Issue:7 Topics: Androgens; Anti-Obesity Agents; Antidepressive Agents; Antihypertensive Agents; Antipsychotic Agents; Appetite Depressants; Benzazepines; Bupropion; Drug Combinations; Fructose; Humans; Hypoglycemic Agents; Hypogonadism; Lactones; Liraglutide; Naltrexone; Obesity; Orlistat; Phentermine; Testosterone; Topiramate; Weight Gain	2017
Pharmacotherapy of Obesity: Clinical Trials to Clinical Practice. Current diabetes reports, 2017, Volume: 17, Issue:5 Topics: Anti-Obesity Agents; Benzazepines; Clinical Trials as Topic; Fructose; Humans; Life Style; Liraglutide; Obesity; Phentermine; Topiramate; Weight Loss	2017
Current pharmacotherapies for obesity: A practical perspective. Journal of the American Association of Nurse Practitioners, 2017, Volume: 29, Issue:S1 Topics: Adult; Anti-Obesity Agents; Benzazepines; Female; Humans; Lactones; Liraglutide; Middle Aged; Naltrexone; Obesity; Orlistat; Phentermine; Risk Reduction Behavior; United States	2017
Pharmacotherapy for obesity: What you need to know. Cleveland Clinic journal of medicine, 2017, Volume: 84, Issue:12 Topics: Adult; Anti-Obesity Agents; Appetite Depressants; Benzazepines; Bupropion; Drug Combinations; Humans; Lactones; Liraglutide; Naltrexone; Obesity; Orlistat; Phentermine	2017
Pharmacotherapy for obesity in individuals with type 2 diabetes. Expert opinion on pharmacotherapy, 2018, Volume: 19, Issue:3 Topics: Anti-Obesity Agents; Benzazepines; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Compounding; Humans; Lactones; Liraglutide; Obesity; Orlistat; Phentermine; Weight Loss	2018
Treating obesity in patients with cardiovascular disease: the pharmacotherapeutic options. Expert opinion on pharmacotherapy, 2019, Volume: 20, Issue:5 Topics: Anti-Obesity Agents; Benzazepines; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Liraglutide; Obesity; Orlistat; Phentermine; Weight Loss	2019
Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand? Current obesity reports, 2021, Volume: 10, Issue:1 Topics: Animals; Anti-Obesity Agents; Benzazepines; Bupropion; Humans; Liraglutide; Naltrexone; Obesity; Orlistat; Overweight; Phentermine; Topiramate; United States; United States Food and Drug Administration; Weight Loss	2021

Trials

2 trial(s) available for phentermine and lorcaserin

Article	Year
Coadministration of lorcaserin and phentermine for weight management: A 12-week, randomized, pilot safety study. Obesity (Silver Spring, Md.), 2017, Volume: 25, Issue:5 Topics: Adolescent; Adult; Anti-Obesity Agents; Benzazepines; Double-Blind Method; Female; Humans; Male; Middle Aged; Phentermine; Pilot Projects; Weight Loss; Young Adult	2017
Effect of Lorcaserin Alone and in Combination with Phentermine on Food Cravings After 12-Week Treatment: A Randomized Substudy. Obesity (Silver Spring, Md.), 2018, Volume: 26, Issue:2 Topics: Adolescent; Adult; Anti-Obesity Agents; Benzazepines; Craving; Female; Humans; Male; Middle Aged; Obesity; Overweight; Phentermine; Young Adult	2018

Other Studies

22 other study(ies) available for phentermine and lorcaserin

Article	Year
Market watch: upcoming market catalysts in Q3 2010. Nature reviews. Drug discovery, 2010, Volume: 9, Issue:7 Topics: Anti-Obesity Agents; Benzazepines; Drug Approval; Drug Combinations; Drug Evaluation, Preclinical; Fructose; Humans; Phentermine; Topiramate; United States; United States Food and Drug Administration	2010
What cost weight loss? Circulation, 2012, Mar-06, Volume: 125, Issue:9 Topics: Anti-Obesity Agents; Benzazepines; Bupropion; Cyclobutanes; Fructose; Humans; Naltrexone; Obesity; Phentermine; Risk Assessment; Risk Factors; Topiramate; Weight Loss	2012
Two anti-obesity hopefuls and their safety. Expert opinion on drug safety, 2012, Volume: 11, Issue:5 Topics: Adult; Anti-Obesity Agents; Benzazepines; Dose-Response Relationship, Drug; Drug Combinations; Drugs, Investigational; Female; Fructose; Heart Valve Diseases; Humans; Male; Obesity; Phentermine; Pregnancy; Tachycardia; Teratogens; Topiramate; Weight Loss	2012
Regulatory fog lifts on obesity drugs. Nature biotechnology, 2012, Volume: 30, Issue:9 Topics: Anti-Obesity Agents; Benzazepines; Drug Combinations; Fructose; Legislation, Drug; Phentermine; United States; United States Food and Drug Administration	2012
2 new drugs for weight loss. The Medical letter on drugs and therapeutics, 2012, Sep-03, Volume: 54, Issue:1398 Topics: Anti-Obesity Agents; Benzazepines; Drug Combinations; Drug Interactions; Fructose; Humans; Obesity; Overweight; Phentermine; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT2 Receptor Agonists; Treatment Outcome; Weight Loss	2012
The FDA's assessment of two drugs for chronic weight management. The New England journal of medicine, 2012, Oct-25, Volume: 367, Issue:17 Topics: Abnormalities, Drug-Induced; Anti-Obesity Agents; Benzazepines; Delayed-Action Preparations; Drug Approval; Drug Combinations; Female; Fructose; Humans; Obesity; Phentermine; Pregnancy; Serotonin Receptor Agonists; Topiramate; United States; United States Food and Drug Administration; Weight Loss	2012
Two new drugs approved for obesity. South Dakota medicine : the journal of the South Dakota State Medical Association, 2012, Volume: 65, Issue:9 Topics: Anti-Obesity Agents; Benzazepines; Body Mass Index; Drug Approval; Drug Combinations; Fructose; Humans; Obesity; Phentermine; Topiramate; United States; United States Food and Drug Administration	2012
Therapies for obesity and medication-associated weight gain. Journal of psychosocial nursing and mental health services, 2013, Volume: 51, Issue:5 Topics: Animals; Appetite Depressants; Bariatric Surgery; Benzazepines; Bupropion; Chronic Disease; Combined Modality Therapy; Diet, Reducing; Disease Models, Animal; Drug Combinations; Exercise; Fructose; Humans; Mood Disorders; Naltrexone; Obesity; Overweight; Phentermine; Psychotic Disorders; Randomized Controlled Trials as Topic	2013
New medications for weight loss. JAAPA : official journal of the American Academy of Physician Assistants, 2012, Volume: 25, Issue:12 Topics: Appetite Depressants; Benzazepines; Drug Combinations; Fructose; Humans; Obesity; Overweight; Phentermine; Weight Loss	2012
High demand likely for prescription weight-control drugs. Mayo Clinic health letter (English ed.), 2012, Volume: 30, Issue:11 Topics: Appetite Depressants; Benzazepines; Drug Utilization; Fructose; Humans; Obesity; Phentermine; Prescription Drugs; Topiramate; United States; Weight Loss	2012
The new weight-loss drugs, lorcaserin and phentermine-topiramate: slim pickings? JAMA internal medicine, 2014, Volume: 174, Issue:4 Topics: Anti-Obesity Agents; Benzazepines; Female; Fructose; Humans; Male; Obesity; Phentermine; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Topiramate; United States; United States Food and Drug Administration; Weight Loss	2014
The FDA's risk/benefit calculus in the approvals of Qsymia and Belviq: treating an obesity epidemic while avoiding another fen-phen. Food and drug law journal, 2014, Volume: 69, Issue:1 Topics: Anti-Obesity Agents; Benzazepines; Drug Approval; Drug Combinations; Fructose; Humans; Obesity; Phentermine; Risk Assessment; United States; United States Food and Drug Administration	2014
Aetna includes medications in weight-loss strategies. Managed care (Langhorne, Pa.), 2014, Volume: 23, Issue:7 Topics: Anti-Obesity Agents; Benzazepines; Drug Combinations; Fructose; Humans; Managed Care Programs; Organizational Case Studies; Phentermine; United States; Weight Reduction Programs	2014
Lorcaserin, phentermine topiramate combination, and naltrexone bupropion combination for weight loss: the 15-min challenge to sort these agents out. International journal of clinical practice, 2014, Volume: 68, Issue:12 Topics: Benzazepines; Bupropion; Drug Combinations; Drug Prescriptions; Fructose; Humans; Naltrexone; Obesity; Phentermine; Topiramate; Weight Loss	2014
Pharmacological treatment of obesity in Europe: waiting for the arrival of the white blackbird. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2014, Volume: 61, Issue:10 Topics: Anti-Obesity Agents; Appetite Depressants; Benzazepines; Bupropion; Clinical Trials as Topic; Drug Approval; Drug Combinations; Europe; Fructose; Humans; Naltrexone; Obesity; Phentermine; Product Surveillance, Postmarketing; Topiramate; United States; United States Food and Drug Administration	2014
Nonincretin drugs in later-stage development. The American journal of managed care, 2014, Volume: 20, Issue:1 Spec No. Topics: Anti-Obesity Agents; Benzazepines; Benzoxazines; Bupropion; Drug Combinations; Drug Labeling; Drugs, Investigational; Fructose; Humans; Naltrexone; Obesity; Phentermine; United States; United States Food and Drug Administration	2014
Review of pharmacotherapy options for the management of obesity. Journal of the American Association of Nurse Practitioners, 2016, Volume: 28, Issue:2 Topics: Benzazepines; Bupropion; Disease Management; Fructose; Humans; Lactones; Liraglutide; Naltrexone; Obesity; Orlistat; Phentermine; Topiramate; United States	2016
Answers to Clinical Questions in the Primary Care Management of People with Obesity: Pharmacologic Management. The Journal of family practice, 2016, Volume: 65, Issue:7 Suppl Topics: Anti-Obesity Agents; Benzazepines; Body Mass Index; Bupropion; Guidelines as Topic; Humans; Lactones; Life Style; Liraglutide; Naltrexone; Obesity; Orlistat; Overweight; Phentermine; Primary Health Care; Risk Factors; Treatment Outcome; Weight Loss	2016
Obesity Epidemic: Pharmaceutical Weight Loss. Rhode Island medical journal (2013), 2017, Mar-01, Volume: 100, Issue:2 Topics: Anti-Obesity Agents; Benzazepines; Body Mass Index; Bupropion; Drug Combinations; Fructose; Humans; Lactones; Liraglutide; Naltrexone; Obesity; Orlistat; Phentermine; Weight Loss	2017
Observational Comparative Effectiveness of Pharmaceutical Treatments for Obesity within the Veterans Health Administration. Pharmacotherapy, 2018, Volume: 38, Issue:1 Topics: Adult; Aged; Anti-Obesity Agents; Benzazepines; Body Weight; Cohort Studies; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Obesity; Orlistat; Phentermine; Retrospective Studies; Topiramate; United States; United States Department of Veterans Affairs; Weight Loss	2018
Rationale for Utilization of Obesity Pharmacotherapy in the Active Duty Population. Military medicine, 2018, 03-01, Volume: 183, Issue:3-4 Topics: Alcohol Deterrents; Appetite Depressants; Benzazepines; Cohort Studies; Drug Therapy; Humans; Incretins; Liraglutide; Military Personnel; Naltrexone; Obesity; Phentermine; Retrospective Studies	2018
The cardiovascular safety of antiobesity drugs-analysis of signals in the FDA Adverse Event Report System Database. International journal of obesity (2005), 2020, Volume: 44, Issue:5 Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Anti-Obesity Agents; Benzazepines; Cardiovascular Diseases; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Naltrexone; Obesity; Phentermine; United States; United States Food and Drug Administration	2020